Home - Products - Others - Other Targets - Ginsenoside F4

Ginsenoside F4

CAS No. 181225-33-2

Ginsenoside F4( —— )

Catalog No. M31419 CAS No. 181225-33-2

Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
10MG	495	In Stock
50MG	Get Quote	In Stock
100MG	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ginsenoside F4
Note

Research use only, not for human use.
Brief Description

Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
Description

Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
In Vitro

Western Blot Analysis Cell Line:Human lymphocytoma JK cells Concentration:8.15 μM, 65.19 μM, 130.38 μM Incubation Time:Result:Decreased Bcl-2 protein level and increased the Bax level, which changes related to apoptosis.
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

181225-33-2
Formula Weight

767
Molecular Formula

C42H70O12
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 50 mg/mL (65.19 mM)
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Linzagolix

Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
DMPS

Sodium 2,3-dimercaptopropanesulfonate monohydrate
Fluorescein

A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium such as the aqueous humor, used as a diagnostic aid in corneal injuries and corneal trauma.

Sign In Join Free